Pancreatic Cancer Research

ResearcherFujian Medical UniversityNo recent work listed

Chengjie Lin

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5101149133. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2022: 1 paper · 2023: 1 paper

Papers 2

  1. CST2 is activated by RUNX1 and promotes pancreatic cancer progression by activating PI3K/AKT pathway. First author DOI 10.1016/j.abb.2023.109760↗
  2. N6-methyladenosine-mediated SH3BP5-AS1 upregulation promotes GEM chemoresistance in pancreatic cancer by competitively sponging miR-139-5p and activating the W… Co-author DOI 10.21203/rs.3.rs-1242747/v1↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Rongwen Ou · 1 shared paper, 2023 · strength 0.31
  2. Youting Chen · 1 shared paper, 2023 · strength 0.31
  3. Shangeng Weng · 1 shared paper, 2022 · strength 0.17
  4. Liang Wang · 1 shared paper, 2022 · strength 0.17
  5. Xiang Zhang · 1 shared paper, 2022 · strength 0.17
  6. Yan Wang · 1 shared paper, 2022 · strength 0.17
  7. Shihui Lai · 1 shared paper, 2022 · strength 0.17

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.